CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


FamotidineWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug867 Ergoferon Wiki 1.00
drug1822 Placebo Wiki 0.06

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D014777 Virus Diseases NIH 0.12
D003141 Communicable Diseases NIH 0.09
D007239 Infection NIH 0.06

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Famotidine Use in Non-hospitalized Patients With COVID-19: A Case Series

A retrospective case series of patients who self-medicated with Famotidine during coronavirus disease 2019 (COVID-19). The study will collect de-identified patient reported outcome measures of patients with confirmed COVID-19 who self-medicated with Famotidine at any dose during the period of illness. Data will be collected by questionnaire and telephone interview. Inclusion criteria: Age>18; Ability to give written informed consent for study participation; Confirmed diagnosis of COVID-19; Use of Famotidine at any dose during period of COVID-19 illness

NCT04389567 COVID-19 Drug: Famotidine

Primary Outcomes

Description: Symptoms assessed by severity scores on an ordinal scale; 1=not affected to 4= severely affected

Measure: Symptomatic improvement

Time: 2 weeks

Secondary Outcomes

Description: Oxygen saturation determined by pulse oximetry

Measure: Peripheral blood oxygen saturation

Time: 2 weeks


No related HPO nodes (Using clinical trials)